| Zugriffe | |
|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 391 |
| Februar 2025 | März 2025 | April 2025 | Mai 2025 | Juni 2025 | Juli 2025 | August 2025 | |
|---|---|---|---|---|---|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 0 | 21 | 9 | 3 | 11 | 19 | 8 |
| Zugriffe | |
|---|---|
| 3_Chapter3_Materials_Methods.pdf | 289 |
| 6_Chapter6_References.pdf | 286 |
| 1_Chapter1_Introduction_aims_objectives.pdf | 218 |
| 0_Title_Index.pdf | 179 |
| 7_Chapter7_Appendices_Aknowledgements.pdf | 177 |
| 2_Chapter2_Literature_review.pdf | 147 |
| 4_Chapter4_Results_Discussions.pdf | 138 |
| 5_Chapter5_Summary_Zusammenfassung.pdf | 97 |
